| Name | Irsenontrine |
|---|
| Description | Irsenontrine (E2027) is an orally active and selective phosphodiesterase 9 (PDE 9) inhibitor. Irsenontrine can be used for the research of neurological diseases[1]. |
|---|---|
| Related Catalog | |
| Target |
PDE 9[1] |
| In Vitro | Irsenontrine (E2027) is an orally active and selective phosphodiesterase 9 (PDE 9) inhibitor[1]. |
| References |
| Molecular Formula | C22H22N4O3 |
|---|---|
| Molecular Weight | 390.44 |